[严重的大动脉狭窄和家族性高胆固醇血症]
Milagros Mallma Gomez1, Josafat Condori Ccallo1, David Miranda Noé1
1Servicio de Cardiología Clínica, Instituto Nacional Cardiovascular INCOR. Lima, Perú Servicio de Cardiología Clínica Instituto Nacional Cardiovascular INCOR Lima Perú.
Archivos peruanos de cardiologia y cirugia cardiovascular
|September 20, 2023
概括
同胞性家族性高胆固醇血症 (HFH) 是一种罕见的疾病,导致早期心血管问题. 本案例研究详细介绍了一名患有HFH和严重大动脉狭窄症的青少年的手术干预和组合治疗.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 同胞性家族性高胆固醇血症 (HFH) 是一种罕见的遗传性疾病.
- 高血压严重增加了早发性心血管疾病的风险,包括冠状动脉疾病和大动脉狭窄.
- 早期诊断和干预对于管理HFH及其并发症至关重要.
研究的目的:
- 介绍一个青少年男性的病例,诊断出HFH和严重的大动脉狭窄.
- 描述这个复杂病例的手术和医疗管理.
- 强调及时干预儿科HFH的重要性.
主要方法:
- 临床诊断HFH和严重的大动脉狭窄.
- 外科干预包括以机械假肢替换大动脉门和大动脉环扩大.
- 由于手术后的并发症,植入了两个冠状动脉旁路.
- 在出院后开始使用高强度他类药物和ezetimibe的联合治疗.
主要成果:
- 患者成功地进行了大动脉置换和绕道手术.
- 患者在术后经历了有利的临床演变.
- 出院药物包括高强度他类药物和ezetimibe的联合治疗.
结论:
- 这一案例表明,成功管理了一名患有严重HFH和大动脉狭窄症的年轻患者.
- 手术干预与降脂药物治疗相结合,可以有效地管理HFH的严重心血管表现.
- 积极的降脂策略对于改善HFH患者的治疗结果至关重要.
相关概念视频
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20


